There has been a tremendous progress in the fields of cell research in China and phamaceutical research in India. Because of a more relaxed legal restriction in human cell and stem cell experiments. There are several Chinese university labs that have come up with near commercial ready products to cure diseases. We have also seen small companies able to make very in-expensive beta carotene and vitamin additives. Many innovative methods such as fomentation techniques are used to mass produce them. For example, China is now the world leader in Vitamin C production. These new products have a great market in China and the world. We will help some of them become public companies in the United States to access expansion capital; and at the same time, to afford our shareholders and investors an opportunity to invest in these growing companies.
